Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population

Aims We described the presence of Helicobacter pylori (HP) and estimated the prevalence of primary and secondary resistance using molecular detection in gastric biopsies of Ecuadorian patients. Methods and Results 66.7% (238/357) of the patients demonstrated the presence of HP using CerTest qPCR. Of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of applied microbiology 2022-04, Vol.132 (4), p.2694-2704
Hauptverfasser:	Zurita, Jeannete, Sevillano, Gabriela, Paz y Miño, Ariane, Zurita‐Salinas, Camilo, Peñaherrera, Vicente, Echeverría, Manuel, Navarrete, Hugo, Silva Casares, María Ángeles, Orellana Narvaez, Ivonne, Yépez, Juan Esteban, Zaldumbide Serrano, Francisco, Oviedo Valdiviezo, César
Format:	Artikel
Sprache:	eng
Schlagworte:	Amoxicillin Amoxicillin - pharmacology Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use antibiotic resistance Antibiotics Antimicrobial agents Antimicrobial resistance Biopsy Clarithromycin Drug Resistance, Bacterial - genetics Ecuador Eradication genotyping Helicobacter Helicobacter Infections - drug therapy Helicobacter Infections - epidemiology Helicobacter Infections - microbiology Helicobacter pylori Helicobacter pylori - genetics Humans Levofloxacin Metronidazole Metronidazole - pharmacology Metronidazole - therapeutic use Microbial Sensitivity Tests Mutation Patients PCR‐based diagnosis Rifabutin RNA, Ribosomal, 16S rRNA 16S rRNA 23S
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!